Cervical cancer, human papillomavirus, and vaccination.
作者信息
Lowndes Catherine M, Gill O Noel
出版信息
BMJ. 2005 Oct 22;331(7522):915-6. doi: 10.1136/bmj.331.7522.915.
Abstract
摘要
相似文献
1
Cervical cancer, human papillomavirus, and vaccination.宫颈癌、人乳头瘤病毒与疫苗接种
BMJ. 2005 Oct 22;331(7522):915-6. doi: 10.1136/bmj.331.7522.915.
2
Prevention strategies of cervical cancer in the HPV vaccine era.人乳头瘤病毒疫苗时代的宫颈癌预防策略
Gynecol Oncol. 2006 Oct;103(1):21-4. doi: 10.1016/j.ygyno.2006.07.019. Epub 2006 Aug 17.
3
Delivering on the promise: HPV vaccines and cervical cancer.兑现承诺：人乳头瘤病毒疫苗与宫颈癌
Nat Rev Microbiol. 2004 Apr;2(4):343-7. doi: 10.1038/nrmicro867.
4
Effectiveness of preventive human papillomavirus vaccination.预防性人乳头瘤病毒疫苗的有效性。
Int J STD AIDS. 2003 Dec;14(12):787-92. doi: 10.1258/095646203322556084.
5
Vaccination against human papillomaviruses shows great promise.人乳头瘤病毒疫苗显示出巨大的前景。
Lancet. 2004;364(9447):1731-2. doi: 10.1016/S0140-6736(04)17410-2.
6
[Cervical cancer uteri: from the etiology to prophylactic vaccine].子宫颈癌：从病因到预防性疫苗
Cas Lek Cesk. 2006;145(7):511-21.
7
By the way, doctor. Recently, I read about a new vaccine against cancer of the cervix. Is this something I should consider?顺便问一下，医生。最近，我读到一种针对宫颈癌的新疫苗。这是我应该考虑的事情吗？
Harv Womens Health Watch. 2006 Apr;13(8):8.
8
Is the public enough aware to accept a vaccination program against human papillomavirus?公众是否足够了解并接受针对人乳头瘤病毒的疫苗接种计划？
Vaccine. 2005 May 9;23(25):3231. doi: 10.1016/j.vaccine.2005.01.143.
9
Current clinical trials of HPV vaccines.人乳头瘤病毒疫苗的当前临床试验。
Oncology (Williston Park). 2004 Jun;18(7):859-60, 862.
10
[HPV vaccination--a possibility for prevention of cervical cancer].[人乳头瘤病毒疫苗——预防宫颈癌的一种可能性]
Duodecim. 2002;118(21):2159-60.
引用本文的文献
1
Vaccines against human papilloma virus and cervical cancer: an overview.人乳头瘤病毒疫苗与宫颈癌：概述
Indian J Community Med. 2008 Jul;33(3):143-5. doi: 10.4103/0970-0218.42045.
2
Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials.宫颈癌近距离治疗：低剂量率或高剂量率近距离治疗——临床试验的荟萃分析
J Exp Clin Cancer Res. 2009 Apr 5;28(1):47. doi: 10.1186/1756-9966-28-47.
3
Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination.公众对人乳头瘤病毒（HPV）疫苗接种的了解和态度。
BMC Public Health. 2008 Oct 23;8:368. doi: 10.1186/1471-2458-8-368.
4
Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland.人乳头瘤病毒疫苗接种策略：芬兰最佳年龄和性别特异性接种模式的建模
Br J Cancer. 2007 Feb 12;96(3):514-8. doi: 10.1038/sj.bjc.6603575. Epub 2007 Jan 23.
5
Ensuring access to HPV vaccines through integrated services: a reproductive health perspective.从生殖健康角度看，通过综合服务确保获得人乳头瘤病毒疫苗
Bull World Health Organ. 2007 Jan;85(1):57-63. doi: 10.2471/blt.06.034397.
6
An armamentarium of wart treatments.一套疣治疗方法。
Clin Med Res. 2006 Dec;4(4):273-93. doi: 10.3121/cmr.4.4.273.
7
HPV vaccine and adolescents' sexual activity.人乳头瘤病毒疫苗与青少年的性活动
BMJ. 2006 May 13;332(7550):1106-7. doi: 10.1136/bmj.332.7550.1106.
8
Infection and disease: cause and cure.感染与疾病：病因与治疗
J Pathol. 2006 Jan;208(2):131-3. doi: 10.1002/path.1912.
9
Details of HPV immunisation need not delay decision.人乳头瘤病毒疫苗接种的具体情况无需推迟决策。
BMJ. 2005 Nov 5;331(7524):1081. doi: 10.1136/bmj.331.7524.1081-a.
本文引用的文献
1
WHO consultation on human papillomavirus vaccines.世界卫生组织关于人乳头瘤病毒疫苗的磋商会
Wkly Epidemiol Rec. 2005 Sep 2;80(35):299-302.
2
Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.国际癌症研究机构人乳头瘤病毒流行率调查中细胞学正常女性人乳头瘤病毒类型的全球分布：一项汇总分析
Lancet. 2005;366(9490):991-8. doi: 10.1016/S0140-6736(05)67069-9.
3
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.年轻女性预防性四价人乳头瘤病毒（6、11、16和18型）L1病毒样颗粒疫苗：一项随机双盲安慰剂对照多中心II期疗效试验。
Lancet Oncol. 2005 May;6(5):271-8. doi: 10.1016/S1470-2045(05)70101-7.
4
Global cancer statistics, 2002.2002年全球癌症统计数据。
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
5
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.二价L1病毒样颗粒疫苗预防年轻女性感染人乳头瘤病毒16型和18型的疗效：一项随机对照试验
Lancet. 2004;364(9447):1757-65. doi: 10.1016/S0140-6736(04)17398-4.
6
The cervical cancer epidemic that screening has prevented in the UK.在英国，筛查预防的宫颈癌流行情况。
Lancet. 2004;364(9430):249-56. doi: 10.1016/S0140-6736(04)16674-9.
7
Epidemiologic classification of human papillomavirus types associated with cervical cancer.与宫颈癌相关的人乳头瘤病毒类型的流行病学分类
N Engl J Med. 2003 Feb 6;348(6):518-27. doi: 10.1056/NEJMoa021641.
8
A controlled trial of a human papillomavirus type 16 vaccine.一项16型人乳头瘤病毒疫苗的对照试验。
N Engl J Med. 2002 Nov 21;347(21):1645-51. doi: 10.1056/NEJMoa020586.
9
The causal relation between human papillomavirus and cervical cancer.人乳头瘤病毒与宫颈癌之间的因果关系。
J Clin Pathol. 2002 Apr;55(4):244-65. doi: 10.1136/jcp.55.4.244.
10
Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours.英国的性行为：伴侣关系、行为方式及艾滋病病毒风险行为
Lancet. 2001 Dec 1;358(9296):1835-42. doi: 10.1016/S0140-6736(01)06883-0.
Zotero 插件